Seoul, South Korea

Young Kwen Choi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Icure. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Kwen Choi. Retrieved from https://idiyas.com/inventor/young-kwen-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Kwen Choi: Innovator in Transdermal Drug Delivery

Introduction

Young Kwen Choi is a notable inventor based in Seoul, South Korea. He is recognized for his contributions to the field of transdermal drug delivery systems. His innovative approach has led to the development of a unique fentanyl transdermal patch that enhances patient care.

Latest Patents

Young Kwen Choi holds 1 patent for his invention of a fentanyl transdermal patch. This patch features an acrylic-rubber hybrid as a drug-adhesive layer. It is designed to maintain constant fentanyl skin permeability for three days. The patch ensures close contact with the skin, which improves desorption, release by moisture and sweat, and minimizes skin stimulation.

Career Highlights

Throughout his career, Young Kwen Choi has worked with various companies, including Icure and Icure Pharmaceutical Corporation. His work has significantly impacted the pharmaceutical industry, particularly in pain management solutions.

Collaborations

Young Kwen Choi has collaborated with several professionals in his field, including Jung Ju Kim and Jung Sik Lee. These collaborations have contributed to the advancement of his innovative projects.

Conclusion

Young Kwen Choi's work in developing the fentanyl transdermal patch exemplifies his commitment to improving drug delivery systems. His innovations continue to influence the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…